Garheng Kong
Sofinnova Ventures
Garheng is a General Partner at Sofinnova Ventures--a life science focused venture fund with $1 billion under management. He has served as chairman and director on the boards of numerous companies, and operated as interim CEO for two venture-backed companies. For the 10 years prior, he was a General Partner at Intersouth Partners.
Before his career in private equity, Garheng spent time at GlaxoWellcome (clinical development and marketing), McKinsey & Company (associate), and TherOx (business development), a private life science company. He has also been involved in commercializing early-stage technology with the Duke University Office of Science and Technology.
Garheng received his M.D. (Medical Scientist Training Program), Ph.D. in Biomedical Engineering, and M.B.A. from Duke University, graduating at the top of his medical and business school classes. He also holds B.S. degrees in Chemical Engineering and Biological Sciences from Stanford University.